Israeli scientists think they have a cure for cancer, one they say could be offered in a year's time. OneNewsNow spoke to another cancer researcher who is not so sure about that.
Dan Aridor is a founder of the Israeli company developing the new treatment. "Our cancer will be effective from day one, will last a duration of a few weeks, and will have no or minimal side effects at a much lower cost than most other treatments on the market," Aridor tells The Jerusalem post . "We believe we will offer a complete cure for cancer in a year."
A clinical cancer researcher in Tennessee has reason to doubt that. "I think it is extremely early to be able to make any kind of promotional statements like that," says Dr. Jeffrey Allerton. "If we know, cancer is a very serious disease, and at the same time it is a disease that tends to mutate over time. Any time that I see, as a medical oncologist, statements that come out that we have the cure for cancer, 'I am naturally skeptical upfront.'
News of the Israeli scientists' captured the attention of various news outlets, including The Jerusalem Post . The scientists speak of using small molecule inhibitors, something many groups around the world are doing to try different mechanisms in the cancer-causing process in the cells.
"What they say they are doing a little bit differently is that they are using three different molecules at a time to try to cut short the steps in a cell going from a normal cell to a cancerous cell, "Allerton explains.
By inhibiting more than one step at a time, the Research into question can kill the cancers before they have a chance to mutate and become resistant to therapy.
"Now what is doing is laboratory manipulation of cancer cells and also beginning in mice," Dr. Allerton continues. "It's going to be quite some time before they are able to bring this out into human trials."
If you are cure comes out next year and proves either ineffective or not-as-effective as hoped, Allerton says that shouldn? "I think we are getting a lot closer to curing some types of cancer in certain clinical scenarios," he tells OneNewsNow. "And why I'm very careful to say that is because the mechanisms that result in a cell going rogue are so diverse and can change over time."